Panciroli, C.
Lucente, G.
Vidal, L.
Carcereny, E.
Quiroga, V.
Pardo, J. C.
Romeo, M.
Estival, A.
Manzano, J. L.
Pardo, B.
Velarde, J. M.
Esteve, A. M.
Lopez, D.
Mañes, A.
Tuset, V.
Villà, S.
Quintero, C. B. http://orcid.org/0000-0003-0771-0390
Article History
Received: 13 February 2019
Accepted: 21 May 2019
First Online: 29 May 2019
Compliance with ethical standards
:
: Carmen Balana, Margarita Romeo, Jose Luis Manzano, and Enric Carcereny declare an advisory role for Roche. Claudia Panciroli has travel and accommodations paid by Servier and BMS to disclose. Giuseppe Lucente has travel and accommodations paid by Eisai, Bial and Krka to disclose. Vanesa Quiroga has travel and accommodations paid by Roche to disclose. Juan Carlos Pardo has travel and accommodations paid by BMS and Merck to disclose. Anabel Mañes has travel and accommodations paid by Bayern to disclose. Jose Luis Manzano declares an advisory role for Novartis, Amgen, Merck and BMS, and travel and accommodations paid by BMS and Novartis. Enric Carcereny declares an advisory role for MSD and BMS. Laura Vidal has an employment with Novartis to disclose. Anna Estival has travel and accommodations paid by MSD, Pharmamar, and Novartis to disclose. The other authors declare no conflict of interest.
: The study was approved by the Ethics Committee of Hospital Germans Trias i Pujol. The study was performed in accordance with the Declaration of Helsinki.
: All patients gave their signed informed consent.